Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
Future Oncology (London, England)|July 13, 2021
AMELIORATE: early intensification in <i>FLT3</i>-mutated acute myeloid leukemia based on peripheral blast clearance - MYNERVA-GIMEMA AML1919 trialFrancesco Mannelli, Giacomo Gianfaldoni, Paola Guglielmelli, et al.
American Journal of Hematology|March 26, 2022
Integration of multiparameter flow cytometry score improves prognostic stratification provided by standard models in primary myelofibrosisFrancesco Mannelli, Sara Bencini, Giacomo Coltro, et al.
American Journal of Hematology|November 16, 2012
Cytarabine and clofarabine after high-dose cytarabine in relapsed or refractory AML patientsBarbara Scappini, Giacomo Gianfaldoni, Francesco Caracciolo, et al.
Experimental Hematology|June 24, 2015
Multilineage dysplasia as assessed by immunophenotype has no impact on clinical-biological features and outcome of NPM1-mutated acute myeloid leukemiaFrancesco Mannelli, Vanessa Ponziani, Maria Ida Bonetti, et al.
Blood Cancer Journal|February 27, 2020
Validation of the IPSET score for thrombosis in patients with prefibrotic myelofibrosisPaola Guglielmelli, Alessandra Carobbio, Elisa Rumi, et al.
American Journal of Hematology|September 4, 2023
A globally applicable "triple A" risk model for essential thrombocythemia based on Age, Absolute neutrophil count, and Absolute lymphocyte countAyalew Tefferi, Giuseppe G Loscocco, Faiqa Farrukh, et al.
Italian Journal of Pediatrics|November 22, 2015
The burden of bacteremia and invasive diseases in children aged less than five years with fever in ItalyChiara Azzari, Maria Moriondo, Pasquale Di Pietro, et al.
Blood Advances|November 11, 2018
Mayo alliance prognostic system for mastocytosis: clinical and hybrid clinical-molecular modelsAnimesh Pardanani, Sahrish Shah, Francesco Mannelli, et al.
Pageof 9